Rifapentine
From Wikipedia, the free encyclopedia
| Image:Rifapentine.png | |
|
Rifapentine
|
|
| Systematic (IUPAC) name | |
| 3{[(4-cyclopentyl-1-piperazinyl)imino]methyl}rifamycin | |
| Identifiers | |
| CAS number | 61379-65-5 |
| ATC code | J04AB05 |
| PubChem | 5462354 |
| DrugBank | APRD01217 |
| Chemical data | |
| Formula | C47H64N4O12 |
| Mol. weight | 877.031 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Rifapentine (marketed under the brand name Priftin by Aventis) is an antibiotic drug used in the treatment of tuberculosis.
[edit] History
Rifapentin was first synthesized in 1965 by the same company that produced rifampin. The drug was approved by the Food and Drug Administration (FDA) in June 1998.
 |
This antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
